China · Delayed Price · Currency is CNY Hubei Goto Biopharm Group Statistics
Total Valuation
SHE:300966 has a market cap or net worth of CNY 3.27 billion. The enterprise value is 4.60 billion.
| Market Cap | 3.27B |
| Enterprise Value | 4.60B |
Important Dates
The next confirmed earnings date is Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jul 16, 2026 |
Share Statistics
SHE:300966 has 114.21 million shares outstanding. The number of shares has increased by 1.58% in one year.
| Current Share Class | 114.21M |
| Shares Outstanding | 114.21M |
| Shares Change (YoY) | +1.58% |
| Shares Change (QoQ) | -3.93% |
| Owned by Insiders (%) | 43.13% |
| Owned by Institutions (%) | 4.93% |
| Float | 56.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.21 |
| PB Ratio | 3.60 |
| P/TBV Ratio | 4.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 46.84 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.31 |
| EV / EBITDA | 53.75 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 1.45.
| Current Ratio | 0.99 |
| Quick Ratio | 0.37 |
| Debt / Equity | 1.45 |
| Debt / EBITDA | 15.41 |
| Debt / FCF | -32.78 |
| Interest Coverage | -0.95 |
Financial Efficiency
Return on equity (ROE) is -8.31% and return on invested capital (ROIC) is -2.24%.
| Return on Equity (ROE) | -8.31% |
| Return on Assets (ROA) | -1.03% |
| Return on Invested Capital (ROIC) | -2.24% |
| Return on Capital Employed (ROCE) | -2.33% |
| Weighted Average Cost of Capital (WACC) | 5.66% |
| Revenue Per Employee | 704,255 |
| Profits Per Employee | -79,779 |
| Employee Count | 893 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | -22.27M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.29% in the last 52 weeks. The beta is 0.45, so SHE:300966's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +51.29% |
| 50-Day Moving Average | 27.60 |
| 200-Day Moving Average | 22.94 |
| Relative Strength Index (RSI) | 51.80 |
| Average Volume (20 Days) | 6,962,107 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300966 had revenue of CNY 628.90 million and -71.24 million in losses. Loss per share was -0.62.
| Revenue | 628.90M |
| Gross Profit | 75.93M |
| Operating Income | -47.96M |
| Pretax Income | -102.11M |
| Net Income | -71.24M |
| EBITDA | 85.49M |
| EBIT | -47.96M |
| Loss Per Share | -0.62 |
Balance Sheet
The company has 75.48 million in cash and 1.32 billion in debt, with a net cash position of -1.24 billion or -10.88 per share.
| Cash & Cash Equivalents | 75.48M |
| Total Debt | 1.32B |
| Net Cash | -1.24B |
| Net Cash Per Share | -10.88 |
| Equity (Book Value) | 910.61M |
| Book Value Per Share | 7.78 |
| Working Capital | -8.04M |
Cash Flow
In the last 12 months, operating cash flow was 69.91 million and capital expenditures -110.12 million, giving a free cash flow of -40.21 million.
| Operating Cash Flow | 69.91M |
| Capital Expenditures | -110.12M |
| Depreciation & Amortization | 133.45M |
| Net Borrowing | 82.38M |
| Free Cash Flow | -40.21M |
| FCF Per Share | -0.35 |
Margins
Gross margin is 12.07%, with operating and profit margins of -7.63% and -11.33%.
| Gross Margin | 12.07% |
| Operating Margin | -7.63% |
| Pretax Margin | -16.24% |
| Profit Margin | -11.33% |
| EBITDA Margin | 13.59% |
| EBIT Margin | -7.63% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.16%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.16% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.58% |
| Shareholder Yield | -1.42% |
| Earnings Yield | -2.18% |
| FCF Yield | -1.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:300966 has an Altman Z-Score of 0.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.98 |
| Piotroski F-Score | 3 |